Company: REVB
Filing Date: 2025-09-30
Form Type: 424B3
Source: 0001193125-25-225254
Chunk: 13

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-09-30
Form: 424B3
Chunk 13
---
-800-SEC-0330 for further information about the public reference room. The Securities and Exchange Commission also maintains a website that contains reports, proxy and information statements and other information regarding issuers like us that file electronically with the Securities and Exchange Commission. You may access the Securities and Exchange Commission’s web site at http://www.sec.gov.

Statements contained in this prospectus as to the contents of any contract or other document are not necessarily complete, and in each instance we refer you to the copy of the contract or document filed as an exhibit to the registration statement, each such statement being qualified in all respects by such reference.

<div align='center'>11</div>

The Securities and Exchange Commission allows us to incorporate by reference in this prospectus the information that we file with them. Incorporation by reference means that we can disclose important information to you by referring you to other documents that are legally considered to be part of this prospectus. Later information that we file with the Securities and Exchange Commission will automatically update and supersede the information in this prospectus, any supplement and the documents listed below. We incorporate by reference the specific documents listed below and any future filings made with the Securities and Exchange Commission under Section 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934, as amended, including those filed after the date of the initial registration statement and prior to the effectiveness of the registration statement, until all of the shares of common stock covered by this prospectus are sold:

Annual Report on Form 10-K for the period ended December 31, 2024, filed with the SEC on March 6, 2025 (the “Registrant Annual Report”);

Quarterly Reports on Form 10-Q for the period ended March 31, 2025 , filed with the SEC on May 8, 2025 and the period ended June 30, 2025 , filed with the SEC on August 8, 2025;

The Company’s Current Reports on Form 8-K filed on January 7, 2025 , January 21, 2025 , January 30, 2025 , February 11, 2025 , February 24, 2025 , March 6, 2025 , March 17, 2025 , May 8, 2025 , May 28, 2025 , June 4, 2025 , June 25, 2025 , July 9, 202